 |
 |

Ion Channels and Neuronal Dysfunction in Multiple Sclerosis
Stephen G. Waxman, MD, PhD
Arch Neurol. 2002;59:1377-1380.
What causes the signs and symptoms of multiple sclerosis (MS)? It is
almost axiomatic to regard MS as a demyelinating disorder in which axonal
conduction block, caused by loss of myelin, produces clinical deficits. In
addition, during the past few years, increased attention has focused on axonal
degeneration in MS. The available evidence suggests that demyelination provides
a structural correlate for relapsing-remitting disease while axonal degeneration,
which may be associated with atrophy of the brain and spinal cord, produces
nonremitting deficits.
Neurons, of course, are the ultimate mediators of nervous system function
and arbiters of neurologic status. Do surviving neurons in MS, nonatrophic
and with intact axons, exhibit abnormalities at the molecular level, more
subtle than axonal degeneration or neuronal atrophy? If so, are these abnormalities
inconsequential molecular oddities or do they contribute to neuronal injury
or perturb neuronal function? Among the molecules that make up neurons, ion
channels are especially critical because they endow these cells with their
signaling capabilities. Thus far, most studies on neuronal ion channels in
demyelinating diseases have focused on their adaptive roles; restoration of
impulse conduction can occur in chronically demyelinated axons as a result
of the insertion of increased densities of sodium channels within the bared
axon membrane. Emerging evidence, however, is also beginning to suggest that
ion channels within neurons can be involved in maladaptive changes in MS.
Experimental studies in animal models of MS and molecular analysis of
autopsy specimens from humans with MS have begun to raise the possibility
that, in addition to demyelination and axonal degeneration, 2 distinct modes
of dysregulated ion channel expression can injure neurons or interfere with
neuronal signaling in MS. One abnormal mode of ion channel expression suggested
by Kornek et al1 is the ectopic distribution
of calcium channels, which they suggest are up-regulated within the axon membrane
in experimental allergic encephalomyelitis (EAE) and in MS. They used immunocytochemical
methods to examine the distribution of the 1B pore-forming
subunit of the N-type voltage-gated calcium channel. Consistent with earlier
reports, they observed a pattern of staining in the normal brain, which suggested
the presence of substantial numbers of 1B subunits in presynaptic
axon terminals (where they participate in synaptic transmission), but they
observed only low levels of 1B within the plasma membrane
of myelinated axons within normal white matter. In EAE and MS, they observed
a different distribution of 1B immunoreactivity, which was
present at higher levels in axons and axonal spheroids within demyelinating
lesions, in a pattern similar to that of ß-amyloid precursor protein
(APP), a marker of acute axonal injury and possibly of impaired axonal transport.
They interpret these results as indicating that 1B subunits
(which in the normal brain are carried within axons by axoplasmic transport
en route to the presynaptic terminal) are inserted into the demyelinated axon
membrane in EAE and MS.
Since the expression of 1B was studied only at the
protein level (and not at the messenger RNA [mRNA] or functional level), further
studies are needed to confirm and extend these results. Nonetheless, it is
worth considering the consequences of abnormal calcium channel deployment
in demyelinated axons. Kornek et al1 propose
that increased intracellular calcium levels due to activity of voltage-gated
calcium channels may activate calcium-dependent proteases (calpains) that
can degrade important axonal proteins,2-3
thus contributing to axonal injury. Action potentials traveling along the
axon or depolarization triggered by an initial insult, such as inflammation,
could act to activate these channels. Consistent with the hypothesis that
calcium channel activity can contribute to axonal injury, it has been shown
that the blockade of calcium channels (including subtype-specific blockade
of N-type calcium channels4) can protect a
subpopulation of myelinated axons from axotomy-induced and anoxia-induced
degeneration.4-5
A second type of molecular abnormality, termed transcriptional
channelopathy, has been described in cerebellar Purkinje neurons and
may perturb the ability of these cells to encode information in animal models
of MS and in humans with MS.6-7
The timing of action potentials and the occurrence of complex bursts of action
potentials within Purkinje cells are critical for the proper functioning of
the cerebellum in motor control and motor learning.8-10
It is well established that these aspects of Purkinje cell signaling depend
in large part on current flowing through sodium channels.11-12
It is also now known that there are 10 different genes encoding molecularly
distinct sodium channel subtypes, all sharing a common overall structural
motif but with different amino acid sequences that endow them with different
voltage-dependences and kinetic properties.13
Purkinje cell firing patterns are perturbed in mouse mutants in which sodium
channel expression is altered by knockout of specific sodium channel genes,14 and these changes are responsible for cerebellar
ataxia in these mutants.15 To determine whether
different subtypes of sodium channels are expressed in Purkinje cells in demyelinating
disorders, Black et al6 first studied the taiep
rat, a mutant in which myelin is formed normally but subsequently degenerates
owing to an abnormality of oligodendrocytes. Using in situ hybridization and
immunocytochemistry with subtype-specific antibodies, they examined expression
of the Nav1.8 sodium channel, which is normally present only in
spinal sensory neurons and trigeminal neurons (and is not detectable within
the normal brain); earlier studies had shown that the expression of Nav1.8 within spinal sensory neurons changes following axonal transection
and in association with inflammation. Consistent with the selective expression
of Nav1.8 in primary sensory neurons, Nav1.8 was not
detected in control brains. However, there was enhanced expression of Nav1.8 mRNA and of Nav1.8 sodium channel protein within Purkinje
cells following loss of myelin within the brains of taiep rats.
A more recent study examined the expression of the Nav1.8
channel in the brains of mice with chronic relapsing EAE and in postmortem
brain tissue from patients with secondary progressive MS who had a history
of cerebellar deficits.7 As expected, Nav1.8 mRNA was not detectable within the cerebellum of control mice or
humans without neurologic disease. In contrast, Nav1.8 mRNA was
clearly present within Purkinje cells of mice with chronic-relapsing EAE and
in humans with MS (Figure 1A, C,
and E). Translation of the mRNA had occurred, since Nav1.8 protein
was also present (Figure 1B, D,
and F). Taken together, these observations in 2 animal models of MS, and in
humans with MS, show that the Nav1.8 gene
(which is normally inactive in the cerebellum) is aberrantly activated in
Purkinje neurons, producing the Nav1.8 sodium channel protein,
which is not normally present in these cells.
|
|
|
|
Figure 1. Nav1.8 sodium channel
is aberrantly expressed in cerebellar Purkinje cells in patients with multiple
sclerosis (MS). In situ hybridization demonstrates Nav1.8 messenger
RNA in Purkinje cells from patients with MS (A and C) but not in controls
without neurologic disease (E). The inset shows Purkinje cells at higher magnification.
Immunocytochemical analysis with Nav1.8-specific antibodies demonstrates
Nav1.8 protein within Purkinje cells in patients with MS (B, D)
but not in controls (F). The arrowhead indicates unlabeled Purkinje cell.
This figure was modified with permission from Black et al.7
|
|
|
Is the expression of Nav1.8 in Purkinje cells functionally
important? That is, are the Nav1.8 channels functional and, if
so, does their presence within Purkinje cells matter in terms of cerebellar
activity? Because Nav1.8 channels display a unique physiological
signature characterized by depolarized voltage-dependence of inactivation,
slow development of inactivation, and rapid recovery from inactivation,16-17 the expression of these channels
in neurons that normally do not produce them would be predicted to perturb
the firing patterns of these cells. Experimental support for the idea that
Nav1.8 channels can affect neuronal firing patterns has been provided
by observations on 2 model systems. Studies on transgenic mice demonstrate
that identical stimuli produce different patterns of action potentials in
dorsal root ganglion cells (the cells in which Nav1.8 is normally
expressed), depending on whether Nav1.8 channels are present or
not; cells expressing Nav1.8 generate larger action potentials
and, when depolarized, produce pacemaker-like repetitive trains of impulses
that are not seen in cells lacking Nav1.8.18
More recent studies have begun to extend this type of analysis to Purkinje
cells, which under normal circumstances tend to generate complex, stereotyped
bursts consisting of multiple action potentials superimposed on a plateau
depolarization.14 Figure 2 shows the effects of Nav1.8 channels on Purkinje
cells in vitro, which are similar to the effects observed in dorsal root ganglion
cells.18 When Nav1.8 sodium channels
are experimentally expressed within Purkinje cells, the firing pattern changes
markedly; Purkinje cells that express Nav1.8 produce larger action
potentials compared with the responses in Purkinje cells that lack Nav1.8, and the secondary, tertiary, and subsequent action potentials
that contribute to the bursts tend to be eliminated so that bursts are replaced
by single-action potentials (Figure 2A
and C). The responses evoked by depolarizing stimuli are also different: Purkinje
cells expressing Nav1.8 produce pacemaker-like trains of large-amplitude
action potentials that are not seen in normal cells (Figure 2B and D). Thus, similar to dorsal root ganglion cells, Purkinje
cells in vitro produce substantially different patterns of activity as a result
of the expression of Nav1.8.
|
|
|
|
Figure 2. A-D, Expression of Nav1.8
sodium channels perturbs signalling in cultured Purkinje cells. These current-clamp
recordings illustrate action potential activity in a control rat Purkinje
cell (A, B) and in a Purkinje cell in which Nav1.8 sodium channels
were biolistically expressed (C, D). Normal Purkinje cells spontaneously generate
bursts of action potentials superimposed on a plateau depolarization (A).
Following expression of Nav1.8 sodium channels, these bursts are
replaced by single action potentials (C). In response to a depolarizing stimulus
(120 pA, 1 second), Purkinje cells expressing Nav1.8 produce sustained
trains of action potentials (D) that are not seen in normal cells (B).
|
|
|
Since biopsy of cerebellar tissue is not commonly performed in MS, it
will not be easy to establish whether these physiologic changes occur in humans
with MS. Clinical observations, however, provide some support for this suggestion.
The not uncommon clinical observation of patients with MS having cerebellar
deficits on examination but without apparent cerebellar lesions in neuroimaging
studies is consistent with the hypothesis that molecular changes that are
too subtle to be detected by currently available imaging techniques can lead
to dysfunction within the cerebellum. In addition, paroxysmal ataxia has been
well described in MS.19-20 The
temporal profile of the sudden and brief attacks and the therapeutic response
to carbamazepine are not easily explained by demyelination or axonal degeneration.
However, the similarity of these attacks to the paroxysmal episodes that occur
in the episodic ataxias, which are associated with inherited channelopathies,
is consistent with the hypothesis that they are the result of a channelopathy.
Although more research will be needed to fully define the extent and
to understand the causes and physiologic consequences of molecular changes
within neurons in MS, the available information on ion channels may present
some new molecular targets and some new therapeutic opportunities. For example,
if N-type calcium channels are involved in the degeneration of axons in MS,
pharmacologic blockade of these channels might be expected to ameliorate,
at least partially, the loss of axons. This hypothesis could be readily examined
in animal models.
Participation of Nav1.8 sodium channels in the production
of cerebellar deficits in humans with MS, if confirmed by additional experiments,
may also provide a new therapeutic target. In principle, blockade of Nav1.8 channels would be expected to restore normal electrogenesis in
Purkinje cells, thus improving cerebellar function. Nav1.8-specific
channel blocking drugs are not yet available, but this may change since the
deployment of Nav1.8 channels within nociceptive spinal sensory
neurons has made Nav1.8 an attractive molecular target.21 When Nav1.8-specific blocking drugs are
developed, a next step will be to examine the effect of these drugs in animal
models of MS, such as EAE.
Finally, are the transcription or deployment of other subtypes of calcium
or sodium channels or channels selective for other ions altered in MS, and
in how many types of neurons does this occur? There is some evidence for abnormal
expression of the Nav1.2 sodium channel22
and of potassium channels23 in dysmyelinated
axons in animal models. Axons and glial cells are intimately related in myelinated
fibers, and both soluble factor-mediated and contact-mediated signaling from
myelinating glial cells appear to modulate ion channel expression in axons.24-25 Thus, we may learn about other neuronal
channels and receptors that are misexpressed in the demyelinating diseases.
Far from being molecular oddities, these changes in the deployment of ion
channels may be clinically important; although they do not detract from the
importance of demyelination or axonal loss, they may suggest new molecular
mechanisms and novel strategies for treating patients with MS and related
disorders.
AUTHOR INFORMATION
Accepted for publication March 6, 2002.
Corresponding author and reprints: Stephen G. Waxman, MD, PhD, Department
of Neurology LCI 707, Yale School of Medicine, 333 Cedar St, New Haven, CT
06510.
From the Department of Neurology and Paralyzed Veterans of America/Eastern
Paralyzed Veterans Association Neuroscience Research Center, Yale University
School of Medicine, New Haven, Conn, and Center for Restorative Neurology,
Veterans Affairs Hospital, West Haven, Conn.
REFERENCES
 |  |
1. Kornek B, Storch MK, Bauer J, et al. Distribution of a calcium channel subunit in dystrophic axons in multiple
sclerosis and experimental autoimmune encephalomyelitis. Brain. 2001;124:1114-1124.
FREE FULL TEXT
2. Schlaepfer WW, Lee C, Lee VM, Zimmerman UJ. An immunoblot study of neurofilament degradation in situ and during
calcium-activated proteolysis. J Neurochem. 1985;44:502-509.
FULL TEXT
|
ISI
| PUBMED
3. Banik NL, Matzelle DC, Gantt-Wilford G, Osborne A, Hogan EL. Increased calpain content and progressive degradation of neurofilament
protein in spinal cord injury. Brain Res. 1997;752:301-306.
FULL TEXT
|
ISI
| PUBMED
4. Fern R, Ransom BR, Waxman SG. Voltage-gated calcium channels in CNS white matter: role in anoxic
injury. J Neurophysiol. 1995;74:369-378.
FREE FULL TEXT
5. George EB, Glass JD, Griffin JW. Axotomy-induced axonal degeneration is mediated by calcium influx through
ion-specific channels. J Neurosci. 1995;15:6445-6452.
FREE FULL TEXT
6. Black JA, Fjell J, Dib-Hajj S, et al. Abnormal expression of SNS/PN3 sodium channel in cerebellar Purkinje
cells following loss of myelin in the taiep rat. Neuroreport. 1999;10:913-918.
ISI
| PUBMED
7. Black JA, Dib-Hajj S, Baker D, Newcombe J, Cuzner ML, Waxman SG. Sensory neuron specific sodium channel SNS is abnormally expressed
in the brains of mice with experimental allergic encephalomyelitis and humans
with multiple sclerosis. Proc Natl Acad Sci. 2000;97:11598-11602.
FREE FULL TEXT
8. Braitenberg V. Is the cerebellar cortex a biological clock in the millisecond range? Prog Brain Res. 1967;25:334-346.
PUBMED
9. Miall RC, Keating JG, Malkmus M, Thach WT. Simple spike activity predicts occurrence of complex spikes in cerebellar
Purkinje cells. Nat Neurosci. 1998;1:13-15.
FULL TEXT
|
ISI
| PUBMED
10. Mauk MD, Medina JF, Nores WL, Ohyama T. Cerebellar function: coordination, learning or timing? Curr Biol. 2000;10:R522-R525.
11. Llinás R, Sugimori M. Electrophysiological properties of in vitro Purkinje cell somata in
mammalian cerebellar slices. J Physiol. 1980;305:171-195.
FREE FULL TEXT
12. Raman IM, Bean BP. Ionic currents underlying spontaneous action potentials in isolated
cerebellar Purkinje neurons. J Neurosci. 1999;19:1663-1674.
FREE FULL TEXT
13. Goldin AL, Barchi RL, Caldwell JH, et al. Nomenclature of voltage-gated sodium channels. Neuron. 2000;28:365-368.
FULL TEXT
|
ISI
| PUBMED
14. Raman IM, Sprunger LK, Meisler MH, Bean BP. Altered subthreshold sodium currents and disrupted firing patterns
in Purkinje neurons of Scn8a mutant mice. Neuron. 1997;19:881-891.
FULL TEXT
|
ISI
| PUBMED
15. Kohrman DC, Smith MR, Goldin Al, Harris J, Meisler MH. Missense mutation in the sodium channel Scn8a is responsible for cerebellar
ataxia in the mouse mutant jolting. J Neurosci. 1996;16:5993-5999.
FREE FULL TEXT
16. Akopian AN, Sivilotti L, Wood JN. A tetrodotoxin-resistant voltage-gated sodium channel expressed by
sensory neurons. Nature. 1996;379:257-262.
FULL TEXT
| PUBMED
17. Dib-Hajj SD, Ishikawa I, Cummins TR, Waxman SG. Insertion of a SNS-specific tetrapeptide in the S3-S4 linker of D4
accelerates recovery from inactivation of skeletal muscle voltage-gated Na
channel µ1 in HEK293 cells. FEBS Lett. 1997;416:11-14.
FULL TEXT
|
ISI
| PUBMED
18. Renganathan M, Cummins TR, Waxman SG. Contribution of Nav1.8 sodium channels to action potential
electrogenesis in DRG neurons. J Neurophysiol. 2001;86:629-640.
FREE FULL TEXT
19. Andermann F, Cosgrove JBR, Lloyd-Smith D, Walters AM. Paroxysmal dysarthria and ataxia in multiple sclerosis. Neurology. 1959;9:21-216.
20. Espir MLE, Watkins SM, Smith HV. Paroxysmal dysarthria and other transient neurological disturbances
in disseminated sclerosis. J Neurol Neurosurg Psychiatry. 1966;29:323.
ISI
| PUBMED
21. Akopian AN, Souslova V, England S, et al. The tetrodotoxin-resistant sodium channel SNS has a specialized function
in pain pathways. Nat Neurosci. 1999;2:541-548.
FULL TEXT
|
ISI
| PUBMED
22. Westenbroek RE, Noebels JL, Catterall WA. Elevated expression of type II Na+ channels in hypomyelinated axons
of shiverer mouse brain. J Neurosci. 1992;12:2259-2267.
ABSTRACT
23. Wang H, Allen ML, Grigg JJ, Noebels JL, Tempel BL. Hypomyelination alters K+ channel expression in mouse mutants shiverer
and Trembler. Neuron. 1995;15:1337-1347.
FULL TEXT
|
ISI
| PUBMED
24. Boiko T, Rasband MN, Levinson SR, et al. Compact myelin dictates the differential targeting of two sodium channel
isoforms in the same axon. Neuron. 2001;30:91-104.
FULL TEXT
|
ISI
| PUBMED
25. Kaplan MR, Cho MH, Ullian EM, Isom LL, Levinson SR, Barres BA. Differential control of clustering of the sodium channels Nav1.2 and Nav1.6 at developing CNS nodes of Ranvier. Neuron. 2001;30:105-119.
FULL TEXT
|
ISI
| PUBMED
SECTION EDITOR: DAVID E. PLEASURE, MD
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Respiratory Abnormalities Resulting from Midcervical Spinal Cord Injury and their Reversal by Serotonin 1A Agonists in Conscious Rats
Choi et al.
J. Neurosci. 2005;25:4550-4559.
ABSTRACT
| FULL TEXT
Immunopathology of multiple sclerosis
Fox
Neurology 2004;63:S3-S7.
ABSTRACT
| FULL TEXT
|